Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis

American Journal of Obstetrics and Gynecology

Volumn 217, Issue 1, 2017, Pages 27-36

  Jauniaux, Eric ^a   Bhide, Amar ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

cesarean delivery; placenta accreta; placenta previa; prenatal diagnosis; ultrasound

Indexed keywords

CESAREAN SECTION; COLOR DOPPLER FLOWMETRY; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; FEMALE; FETUS ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INCIDENCE; MATERNAL DEATH; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA PREVIA; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRANSVAGINAL ECHOGRAPHY; DIAGNOSTIC IMAGING; MEDLINE; PATHOLOGY; PLACENTA ACCRETA; PREGNANCY; PROSPECTIVE STUDY; REPRODUCTION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

CESAREAN SECTION; FEMALE; HUMANS; HYSTERECTOMY; MEDLINE; PLACENTA ACCRETA; PLACENTA PREVIA; PLACENTATION; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 85017135215     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2017.02.050     Document Type: Review

References (53)

1. Irving, C., Hertig, A.T., A study of placenta accreta. Surg Gynecol Obstet 64 (1937), 178–200.
2. Jauniaux, E., Jurkovic, D., Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta 33 (2012), 244–251.
3. Fox, H., Sebire, N.J., Pathology of the placenta. 3rd ed., 2007, Saunders-Elsevier, Philadelphia.
4. Benirschke, K., Burton, G.J., Baergen, R.N., Pathology of the human placenta. 6th ed., 2012, Springer-Verlag, Berlin.
5. Eller, A.G., Bennett, M.A., Sharshiner, M., et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 117 (2011), 331–337.
6. Silver, R.M., Fox, K.A., Barton, J.R., et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 212 (2015), 561–568.
7. Shamshirsaz, A.A., Fox, K.A., Salmanian, B., et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 212 (2015), 218.e1–218.e9.
8. Chantraine, F., Braun, T., Gonser, M., Henrich, W., Tutschek, B., Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand 92 (2013), 439–444.
9. Weiniger, C.F., Einav, S., Deutsch, L., Ginosar, Y., Ezra, Y., Eid, L., Outcomes of prospectively-collected consecutive cases of antenatal-suspected placenta accreta. Int J Obstet Anesth 22 (2013), 273–279.
10. Hall, T., Wax, J.R., Lucas, F.L., Cartin, A., Jones, M., Pinette, M.G., Prenatal sonographic diagnosis of placenta accreta: impact on maternal and neonatal outcomes. J Clin Ultrasound 42 (2014), 449–455.
11. Fitzpatrick, K., Sellers, S., Spark, P., Kurinczuk, J., Brocklehurst, P., Knight, M., The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG 121 (2014), 62–71.
12. Bailit, J.L., Grobman, W.A., Rice, M.M., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 125 (2015), 683–689.
13. Thurn, L., Lindqvist, P.G., Jakobsson, M., et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 123 (2016), 1348–1355.
14. Bowman, Z.S., Eller, A.G., Bardsley, T.R., Greene, T., Varner, M.W., Silver, R.M., Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol 31 (2014), 799–804.
15. Miller, D.A., Chollet, J.A., Goodwin, T.M., Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 177 (1997), 210–214.
16. Wu, S., Kocherginsky, M., Hibbard, J.U., Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 192 (2005), 1458–1461.
17. Silver, R.M., Landon, M.B., Rouse, D.J., et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 107 (2006), 1226–1232.
18. Fitzpatrick, K.E., Sellers, S., Spark, P., Kurinczuk, J.J., Brocklehurst, P., Knight, M., Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One, 7, 2012, e52893.
19. Bowman, Z.S., Manuck, T.A., Eller, A.G., Simons, M., Silver, R.M., Risk factors for unscheduled delivery in patients with placenta accreta. Am J Obstet Gynecol 210 (2014), e1–e6.
20. Marshall, N.E., Fu, R., Guise, J.M., Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 205 (2011), 262.e1–262.e8.
21. Gyamfi-Bannerman, C., Gilbert, S., Landon, M.B., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment. Obstet Gynecol 120 (2012), 1332–1337.
22. Tabsh, K.M., Brinkman, C.R. 3rd, King, W., Ultrasound diagnosis of placenta increta. J Clin Ultrasound 10 (1982), 288–290.
23. Whiting, P.F., Rutjes, A.W., Westwood, M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155 (2011), 529–536.
24. D'Antonio, F., Iacovella, C., Bhide, A., Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 42 (2013), 509–517.
25. Warshak, C.R., Eskander, R., Hull, A.D., et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 108 (2006), 573–581.
26. Miura, K., Miura, S., Yamasaki, K., et al. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn 28 (2008), 805–809.
27. Fishman, S.G., Chasen, S.T., Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta. J Perinat Med 39 (2011), 693–696.
28. Alchalabi, H., Lataifeh, I., Obeidat, B., Zayed, F., Khader, Y.S., Obeidat, N., Morbidly adherent placenta previa in current practice: prediction and maternal morbidity in a series of 23 women who underwent hysterectomy. J Matern Fetal Neonatal Med 27 (2014), 1734–1737.
29. Rac, M.W., Dashe, J.S., Wells, C.E., Moschos, E., McIntire, D.D., Twickler, D.M., Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol 212 (2015), 343.e1–343.e7.
30. Finberg, H.J., Williams, J.W., Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 11 (1992), 333–343.
31. Twickler, D.M., Lucas, M.J., Balis, A.B., et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 9 (2000), 330–335.
32. Comstock, C.H., Love, J.J. Jr., Bronsteen, R.A., et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 190 (2004), 1135–1140.
33. Japaraj, R.P., Mimin, T.S., Mukudan, K., Antenatal diagnosis of placenta previa accreta in patients with previous cesarean scar. J Obstet Gynaecol Res 33 (2007), 431–437.
34. Masselli, G., Brunelli, R., Casciani, E., et al. Magnetic resonance imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound. Eur Radiol 18 (2008), 1292–1299.
35. Shih, J.C., Palacios Jaraquemada, J.M., Su, Y.N., et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 33 (2009), 193–203.
36. Mansour, S.M., Elkhyat, W.M., Placenta previa-accreta: do we need MR imaging. Egypt J Radiol Nuc Med 42 (2011), 433–442.
37. Calì, G., Giambanco, L., Puccio, G., Forlani, F., Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol 41 (2013), 406–412.
38. Maher, M.A., Abdelaziz, A., Bazeed, M.F., Diagnostic accuracy of ultrasound and MRI in the prenatal diagnosis of placenta accreta. Acta Obstet Gynecol Scand 92 (2013), 1017–1022.
39. Higgins, M.F., Monteith, C., Foley, M., O'Herlihy, C., Real increasing incidence of hysterectomy for placenta accreta following previous cesarean section. Eur J Obstet Gynecol Reprod Biol 171 (2013), 54–56.
40. Creanga, A.A., Bateman, B.T., Butwick, A.J., et al. Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor?. Am J Obstet Gynecol 213 (2015), 384.e1–384.e11.
41. Chantraine, F., Nisolle, M., Petit, P., Schaaps, J.P., Foidart, J.M., Individual decisions in placenta increta and percreta: a case series. J Perinat Med 40 (2012), 265–270.
42. Jauniaux, E., Collins, S.L., Jurkovic, D., Burton, G.J., Accreta placentation. A systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol 215 (2016), 712–721.
43. van den Akker, T., Brobbel, C., Dekkers, O.M., Bloemenkamp, K.W., Prevalence, indications, risk indicators, and outcomes of emergency peripartum hysterectomy worldwide: a systematic review and meta-analysis. Obstet Gynecol 128 (2016), 1281–1294.
44. Govindappagari, S., Wright, J.D., Ananth, C.V., Huang, Y., D'Alton, M.E., Friedman, A.M., Risk of peripartum hysterectomy and center hysterectomy and delivery volume. Obstet Gynecol 128 (2016), 1215–1224.
45. National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman. Clinical guideline. 2010, RCOG Press, London.
46. Royal College of Obstetricians and Gynaecologists. Green-top guideline no. 27: placenta praevia, placenta accreta and vasa praevia. 2011, RCOG Press, London.
47. Jeanty, P., Romero, R., Cantraine, F., Cousaert, E., Hobbins, J.C., Fetal cardiac dimensions: a potential tool for the diagnosis of congenital heart defects. J Ultrasound Med 3 (1984), 359–364.
48. Kirk, J.S., Riggs, T.W., Comstock, C.H., Lee, W., Yang, S.S., Weinhouse, E., Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four-chamber view. Obstet Gynecol 84 (1994), 427–431.
49. Ballas, S., Gitstein, S., Jaffa, A.J., Peyser, M.R., Midtrimester placenta previa: normal or pathologic finding. Obstet Gynecol 54 (1979), 12–14.
50. Reddy, U.M., Abuhamad, A.Z., Levine, D., Saade, G.R., Fetal Imaging Workshop Invited Participants. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med 33 (2014), 745–757.
51. Becker, R.H., Vonk, R., Mende, B.C., Ragosch, V., Entezami, M., The relevance of placental location at 20–23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol 17 (2001), 496–501.
52. Dashe, J.S., McIntire, D.D., Ramus, R.M., Santos-Ramos, R., Twickler, D.M., Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol 99 (2002), 692–697.
53. Quant, H.S., Friedman, A.M., Wang, E., Parry, S., Schwartz, N., Transabdominal ultrasonography as a screening test for second-trimester placenta previa. Obstet Gynecol 123 (2014), 628–633.